GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » 5-Year Yield-on-Cost %

Biomark Diagnostics (FRA:20B) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics 5-Year Yield-on-Cost %?

Biomark Diagnostics's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Biomark Diagnostics's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:20B's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.21
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Biomark Diagnostics's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Biomark Diagnostics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's 5-Year Yield-on-Cost % falls into.



Biomark Diagnostics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Biomark Diagnostics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Biomark Diagnostics  (FRA:20B) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Biomark Diagnostics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (FRA:20B) Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines